drugset
drugset / Trial / NCT03142542

The Efficacy and Safety of Udenafil in Patients With Erectile Dysfunction After Bilateral Nerve-sparing Radical Prostatectomy

NCT03142542 ↗

Phase 4 Unknown 99 enrolled Samsung Medical Center Dong-A ST Co., Ltd. · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

This study evaluates the efficacy and safety of Udenafil dosed once a day in patients with erectile dysfunction after bilateral nerve-sparing radical prostatectomy.

Timeline

Start
2017-05
Primary completion
2019-05
Completion
2019-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Udenafil Small molecule 75 mg Oral

Indications

No indication recorded.